Annual Operating Expenses
$242.16 M
+$71.20 M+41.65%
December 31, 2023
Summary
- As of February 12, 2025, DYN annual total operating expenses is $242.16 million, with the most recent change of +$71.20 million (+41.65%) on December 31, 2023.
- During the last 3 years, DYN annual operating expenses has risen by +$183.51 million (+312.91%).
- DYN annual operating expenses is now at all-time high.
Performance
DYN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$105.66 M
+$33.70 M+46.83%
September 30, 2024
Summary
- As of February 12, 2025, DYN quarterly total operating expenses is $105.66 million, with the most recent change of +$33.70 million (+46.83%) on September 30, 2024.
- Over the past year, DYN quarterly operating expenses has increased by +$33.70 million (+46.83%).
- DYN quarterly operating expenses is now at all-time high.
Performance
DYN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DYN Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +41.6% | +46.8% |
3 y3 years | +312.9% | +58.3% |
5 y5 years | +4950.3% | +58.3% |
DYN Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +61.4% | at high | +195.3% |
5 y | 5-year | at high | +1651.5% | at high | +1831.6% |
alltime | all time | at high | +4950.3% | at high | +2811.5% |
Dyne Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $105.66 M(+46.8%) |
Jun 2024 | - | $71.96 M(+4.1%) |
Mar 2024 | - | $69.16 M(+2.2%) |
Dec 2023 | $242.16 M(+41.6%) | $67.69 M(+8.7%) |
Sep 2023 | - | $62.27 M(-6.7%) |
Jun 2023 | - | $66.74 M(+46.8%) |
Mar 2023 | - | $45.46 M(+13.2%) |
Dec 2022 | $170.96 M(+14.0%) | $40.15 M(-5.0%) |
Sep 2022 | - | $42.28 M(-19.9%) |
Jun 2022 | - | $52.76 M(+47.4%) |
Mar 2022 | - | $35.78 M(-31.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $150.03 M(+155.8%) | $51.96 M(+21.5%) |
Sep 2021 | - | $42.77 M(+41.8%) |
Jun 2021 | - | $30.16 M(+20.0%) |
Mar 2021 | - | $25.13 M(-12.1%) |
Dec 2020 | $58.65 M(+324.2%) | $28.60 M(+111.5%) |
Sep 2020 | - | $13.52 M(+55.9%) |
Jun 2020 | - | $8.68 M(+10.5%) |
Mar 2020 | - | $7.85 M(+43.6%) |
Dec 2019 | $13.83 M(+188.3%) | $5.47 M(+50.7%) |
Sep 2019 | - | $3.63 M |
Dec 2018 | $4.79 M | - |
FAQ
- What is Dyne Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Dyne Therapeutics?
- What is Dyne Therapeutics annual operating expenses year-on-year change?
- What is Dyne Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly operating expenses year-on-year change?
What is Dyne Therapeutics annual total operating expenses?
The current annual operating expenses of DYN is $242.16 M
What is the all time high annual operating expenses for Dyne Therapeutics?
Dyne Therapeutics all-time high annual total operating expenses is $242.16 M
What is Dyne Therapeutics annual operating expenses year-on-year change?
Over the past year, DYN annual total operating expenses has changed by +$71.20 M (+41.65%)
What is Dyne Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of DYN is $105.66 M
What is the all time high quarterly operating expenses for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly total operating expenses is $105.66 M
What is Dyne Therapeutics quarterly operating expenses year-on-year change?
Over the past year, DYN quarterly total operating expenses has changed by +$33.70 M (+46.83%)